Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 481–500 of 17,529 recalls

July 29, 2025· Amerisource Health Services LLC

Recalled Item: Sucralfate Tablets

The Issue: CGMP Deviations: The recalling firm filed for Chapter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 29, 2025· Pfizer

Recalled Item: Levoxyl (levothyroxine sodium tablets

The Issue: Subpotent drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 25, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 25, 2025· Alembic Pharmaceuticals Limited

Recalled Item: Doxepin Hydrochloride Capsules

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 24, 2025· Cipla USA, Inc.

Recalled Item: Albuterol Sulfate

The Issue: Failed Stability Specifications: Out of specification results was

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
July 22, 2025· Taizhou Kangping Medical Science And Technology Co., Ltd.

Recalled Item: BZK Antiseptic Towelette

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 22, 2025· Hikma Pharmaceuticals USA Inc.

Recalled Item: Lorazepam Injection

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 21, 2025· YANGZHOU YULOU PAPER PRODUCTS CO., LTD

Recalled Item: Quick Touch Alcohol Prep Pads(Isopropyl Alcohol 70%)

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 21, 2025· Ascend Laboratories, LLC

Recalled Item: Amlodipine and Olmesartan Medoxomil Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 21, 2025· Merck & Co. Inc

Recalled Item: Belsomra (suvorexant) tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide + Cyanocobalamin injection solution

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund